Loading clinical trials...
Loading clinical trials...
A 24-month Randomized Multicenter Study Evaluating Efficacy, Safety, Tolerability and Pharmacokinetics of Sotrastaurin and Tacrolimus vs. a Tacrolimus/Mycophenolate Mofetil-based Control Regimen in de Novo Liver Transplant Recipients
Conditions
Interventions
MMF(1000mg bid) + tacrolimus + standard of care medications
sotrastaurin (200mg bid) + tacrolimus + standard of care medications
+2 more
Locations
39
United States
Novartis Investigative Site
Los Angeles, California, United States
Novartis Investigative Site
San Francisco, California, United States
Novartis Investigative Site
Detroit, Michigan, United States
Novartis Investigative Site
Minneapolis, Minnesota, United States
Novartis Investigative Site
Rochester, Minnesota, United States
Novartis Investigative Site
Cincinnati, Ohio, United States
Start Date
April 1, 2010
Primary Completion Date
July 1, 2012
Completion Date
July 1, 2012
Last Updated
December 22, 2020
NCT05428267
NCT07233096
NCT06717919
NCT06899867
NCT05237583
NCT06703008
Lead Sponsor
Novartis Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions